Terms: = Head and neck cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
849 results:
1. Assessment of the Dosimetric Index from IMRT and Rapid arc Plan for Oropharyngeal cancer with Simultaneous Integrated Boost (SIB) Technique in Combination with EUD-based NTCP and TCP Radiobiological Models.
Dashnamoorthy S; Jeyasingh E; Rajamanickam K; Ahmed I
Asian Pac J Cancer Prev; 2024 May; 25(5):1515-1528. PubMed ID: 38809623
[TBL] [Abstract] [Full Text] [Related]
2. Transcriptomic characteristics according to tumor size and SUV
Ju SH; Lee SE; Yi S; Choi NR; Kim KH; Kim SM; Koh JY; Kim SK; Kim SY; Heo JY; Park JO; Park S; Koo BS; Kang YE
Sci Rep; 2024 May; 14(1):11005. PubMed ID: 38745021
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy of the collapsed cone algorithm calculated radiotherapy plans in intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT): A comparative dosimetric study in tumors of thorax.
Mishra A; Pathak R; Mittal KK; Srivastava AK; Dayashankar MS; Mishra SP; Singh SK
J Cancer Res Ther; 2024 Jan; 20(1):383-388. PubMed ID: 38554350
[TBL] [Abstract] [Full Text] [Related]
4. Incidental [18F]FDG-avid focuses in parotid glands on PET/CT.
Klug TE; Hillerup S; Dias AH; Gormsen LC; Kristensen PN
Acta Otolaryngol; 2024 Feb; 144(2):147-152. PubMed ID: 38530196
[TBL] [Abstract] [Full Text] [Related]
5. Automatic IMRT treatment planning through fluence prediction and plan fine-tuning for nasopharyngeal carcinoma.
Cai W; Ding S; Li H; Zhou X; Dou W; Zhou L; Song T; Li Y
Radiat Oncol; 2024 Mar; 19(1):39. PubMed ID: 38509540
[TBL] [Abstract] [Full Text] [Related]
6. Re-irradiation spine stereotactic body radiotherapy following high-dose conventional radiotherapy for metastatic epidural spinal cord compression: a retrospective study.
Koide Y; Haimoto S; Shimizu H; Aoyama T; Kitagawa T; Shindo Y; Nagai N; Hashimoto S; Tachibana H; Kodaira T
Jpn J Radiol; 2024 Jun; 42(6):662-672. PubMed ID: 38413551
[TBL] [Abstract] [Full Text] [Related]
7. Biomechanical imaging biomarker during chemoradiotherapy predicts treatment response in head and neck squamous cell carcinoma.
Fujimoto K; Shiinoki T; Kawazoe Y; Yuasa Y; Mukaidani W; Manabe Y; Kajima M; Tanaka H
Phys Med Biol; 2024 Feb; 69(5):. PubMed ID: 38359451
[No Abstract] [Full Text] [Related]
8. Updates on the genetics of multiple endocrine neoplasia.
Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
[TBL] [Abstract] [Full Text] [Related]
9. Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4
Kovacsovics-Bankowski M; Sweere JM; Healy CP; Sigal N; Cheng LC; Chronister WD; Evans SA; Marsiglio J; Gibson B; Swami U; Erickson-Wayman A; McPherson JP; Derose YS; Eliason AL; Medina CO; Srinivasan R; Spitzer MH; Nguyen N; Hyngstrom J; Hu-Lieskovan S
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38233101
[TBL] [Abstract] [Full Text] [Related]
10. Risk of malignancy in incidental oropharyngeal lesions exhibiting fluorodeoxyglucose uptake which proceed to tissue biopsy.
Key S; Chia C; Magarey M; Dixon B
ANZ J Surg; 2024 Feb; 94(1-2):122-127. PubMed ID: 38115646
[TBL] [Abstract] [Full Text] [Related]
11. A large language model's assessment of methodology reporting in head and neck surgery.
Dang R; Hanba C
Am J Otolaryngol; 2024; 45(2):104145. PubMed ID: 38103488
[TBL] [Abstract] [Full Text] [Related]
12. Developing the POTOMAC Model: A Novel Prediction Model to Study the Impact of Lymphopenia Kinetics on Survival Outcomes in head and neck cancer Via an Ensemble Tree-Based Machine Learning Approach.
Kut C; Midthune D; Lee E; Fair P; Cheunkarndee T; McNutt T; DeWeese T; Fakhry C; Kipnis V; Quon H
JCO Clin Cancer Inform; 2023 Sep; 7():e2300058. PubMed ID: 38096467
[TBL] [Abstract] [Full Text] [Related]
13. The clinical acceptability of short versus long duration acquisitions for head and neck cancer using long-axial field-of-view PET/CT: a retrospective evaluation.
Mei R; Pyka T; Sari H; Fanti S; Afshar-Oromieh A; Giger R; Caobelli F; Rominger A; Alberts I
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1436-1443. PubMed ID: 38095670
[TBL] [Abstract] [Full Text] [Related]
14. Differentiation of cancer of unknown primary and lymphoma in head and neck metastatic poorly differentiated cancer using 18 F-FDG PET/CT tumor metabolic heterogeneity index.
Xu M; Gu B; Zhang J; Xu X; Qiao Y; Hu S; Song S
Nucl Med Commun; 2024 Feb; 45(2):148-154. PubMed ID: 38095143
[TBL] [Abstract] [Full Text] [Related]
15. A modified U-net with graph representation for dose prediction in esophageal cancer radiotherapy plans.
Chen Y; Yang W; Lu J; Sun J; Rao L; Zhao H; Peng X; Ni D
Comput Med Imaging Graph; 2024 Jan; 111():102318. PubMed ID: 38088017
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of bone SUV obtained from different SPECT/CT systems.
Yoshimura M; Kugai N; Aida T; Hakamata D; Miyajima N; Takahashi Y
Hell J Nucl Med; 2023; 26(3):181-186. PubMed ID: 38085833
[TBL] [Abstract] [Full Text] [Related]
17. 68 Ga-DOTATATE PET to Characterize Lesions in the Neuroaxis.
Hartmann K; Gillman JA; Lazor JW; Ware JB; Weeks JK; Nasrallah IM; Farwell MD; Pantel AR
Clin Nucl Med; 2024 Jan; 49(1):9-15. PubMed ID: 38048554
[TBL] [Abstract] [Full Text] [Related]
18. 18 F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapy.
Valkema MJ; de Lussanet de la Sablonière QG; Valkema R; Thomeer MGJ; Dwarkasing RS; Harteveld AA; Doukas M; Mostert B; van der Zijden CJ; van der Sluis PC; Lagarde SM; Wijnhoven BPL; Verburg FA; van Lanschot JJB
Nucl Med Commun; 2024 Feb; 45(2):128-138. PubMed ID: 37982560
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic Performance of Thyroid Nodule Risk Stratification Systems: Comparison of ACR-TIRADS, EU-TIRADS, K-TIRADS, and ATA Guidelines.
Yucel S; Balci IG; Tomak L
Ultrasound Q; 2023 Dec; 39(4):206-211. PubMed ID: 37918114
[TBL] [Abstract] [Full Text] [Related]
20. Correlation between L-amino acid transporter 1 expression and 4-borono-2-
Kashihara T; Mori T; Nakaichi T; Nakamura S; Ito K; Kurihara H; Kusumoto M; Itami J; Yoshimoto S; Igaki H
Cancer Med; 2023 Nov; 12(21):20564-20572. PubMed ID: 37881128
[TBL] [Abstract] [Full Text] [Related]
[Next]
